Value of Post-Therapy Whole-Body I-131 Imaging in the Evaluation of Patients with Thyroid Carcinoma Having Undergone High-Dose I-131 Therapy

Spies, William G.; Wojtowicz, C. H.; Spies, S. M.; Shah, A.; Zimmer, Aline

doi:10.1097/00003072-198911000-00001

Cited by 69 publications

(25 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Because the patient preparation protocol was strictly standardized and fixed 131 I activities were administered, the mass of the thyroid remnants (which largely depends on the quality of surgery) most likely accounts for the majority of variation in success of ablation in the present patient population. 23,24 This is reflected in our findings that preablative 99m Tc scan and serum Tg levels, both of which are related to the mass of functioning thyroid cells, predicted the ablation rate after radioiodine treatment.…”

Section: Discussionmentioning

confidence: 60%

Postsurgical thyroid remnant estimation by ^99mTc‐pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma

et al. 2010

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 60%

Postsurgical thyroid remnant estimation by ^99mTc‐pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma

et al. 2010

View full text Add to dashboard Cite

show abstract

“…Tüm vucut sintigrafisinin ameliyat sonrası 4-6 hafta sonra yapılmasının sebepleri; operasyon alanının kanlanmasının ancak bu sürede düzelmesi, dolaşımdaki T4' ün düşmesi ve eğer ameliyat öncesi dönemde lugol iyot kullanılmışsa bunun atılmasının sağlanmasıdır (23). Başarılı ablasyonun kararı takipte yapılan tüm vücut iyot sintigrafisinde lokal boyun aktivitesinin olmaması ile verilir (24). Diferansiye tiroid kanserlerinin tedavisi tartışmalıdır: Bazı cerrahlar total tiroidektomiden daha az kapsamlı bir ameliyatın yeterli olabileceğini düşünürler; ancak çoğunluk total tiroidektomi taraftarıdır.…”

Section: Discussionunclassified

Is Morbıdıty Hıgh in Completıon Thyroıdectomy?

Gür¹,

Madenci²,

Çıtlak³

et al. 2018

Haseki

View full text Add to dashboard Cite

ÖzAmaç: Primer olarak yapılan total tiroidektomi ile tamamlayıcı tiroidektomiyi ameliyat sonrası morbidite açısından karşılaştırmayı amaçladık. Yöntemler: Haseki Eğitim ve Araştırma Hastanesi Genel CerrahiKliniği'nde yapılan tamamlayıcı tiroidektomi ameliyatları ile primer total tiroidektomi ameliyatlarındaki morbidite retrospektif olarak incelendi. Cerrah tercihine göre nöromonitorizasyonun kullanılmadığı, ardışık olarak ameliyat edilen hastalar değerlendirilmiştir. Bulgular:İncelenen parametrelerden hiçbirinde yaş (p=0.207), cinsiyet (p=0.998), hormon durumu (p=0.287), nodül mevcudiyeti (p=0.287), çıkarılan lob sayısı (p=0.695), multisentrisite (p=0.081) komplikasyon oluşumu ile çalışıldığında hiçbirinde istatistiksel anlam farkı saptanmadı. Göreli orantı yönünden (odds ratio) 11.9 kat daha fazla komplikasyon riskinin ikinci ameliyat için uygun sürenin dikkate alınmadığı hastalarda oluştuğu görüldü.Tüm hastalar ele alındığında komplikasyon varlığının dağılımı tamamlayıcı tiroidektomi yapılan grupta (grup 2), ilk baştan total tiroidektomi yapılan gruptan (grup 1) anlamlı derecede yüksek bulunmuştur (p=0.003). Grup 2'de komplikasyon gelişme olasılığı Grup 1'den 10.6 kat (odds ratio) fazla gözlenmiştir. Sinir ve paratiroid hasarlarının hiçbiri kalıcı olmamıştır. Sonuç:Günümüzde teknolojik gelişmeler ve ameliyat öncesi tanı yöntemleri tamamlayıcı tiroidektomi gereksinimini azaltsa da, yapıldığında komplikasyon olasılığı baştan total tiroidektomi yapılan hastalardan daha fazladır. Ancak deneyimli ellerde kalıcı komplikasyon oranı değişmemektedir.Anahtar Sözcükler: Total tiroidektomi, tamamlayıcı tiroidektomi, diferansiye tiroid kanseri Aim: We aimed to compare primary total thyroidectomy and completion thyroidectomy in terms of postoperative morbidity. Methods:The morbidity of primary thyroidectomy operations and completion thyroidectomy operations performed at Haseki Training and Research Hospital General Surgery Clinic were evaluated retrospectively. Consecutive patients, in whom neuromonitorization was not used according to the surgeon's choice, were enrolled for study and control groups.Results: There were no statistically significant difference in age, sex (p=0.998),hormonal status (p=0.287),presence of nodule (p=0.287),number of lobes removed (p=0.695), multicentricity (p=0.081)in regard to complications.It was seen that the risk ratio (the odds ratio) was 11.9 times higher in patients in whom appropriate time was not waited for the second operation.When all patients were evaluated, the distribution of complication was found to be significantly higher in the group with completion thyroidectomy (group 2) than in the group with total thyroidectomy (group 1) (p=0.003).The probability of developing complications in Group 2 was 10.6 fold (odds ratio) higher than Group 1.Neither nerve nor parathyroid damage was permanent. Conclusion:Although technological developments and preoperative diagnostic methods reduce the need for completion thyroidectomy nowadays,the probability of complication is higher than that of pati...

show abstract

“…Сцинтиграфия всего тела [205][206][207][208][209][210][211][212][213][214][215][216] Рекомендация 42. У пациентов с био-химической ремиссией после РЙТ проведе-ние плановой СВТ не показано.…”

Section: определение тиреоглобулина и антител к тиреоглобулинуunclassified

2016 Russian clinical practice guidelines for differentiated thyroid cancer diagnosis and treatment

et al. 2017

View full text Add to dashboard Cite

В представленных клинических рекомендациях обсуждаются современные подходы к диагностике и лечению дифференцированного рака щитовидной железы у взрослых. Изменения в настоящей редакции Клинических рекомендаций касаются показаний к пункционной биопсии, скринингового определения концентрации кальцитонина, унификации заключений цитологического исследования, новых подходах к послеоперационной динамической стратификации риска рецидива, показаний к супрессивной и заместительной терапии, таргетной терапии йоднегативных форм дифференцированного рака щитовидной железы.

show abstract

Value of Post-Therapy Whole-Body I-131 Imaging in the Evaluation of Patients with Thyroid Carcinoma Having Undergone High-Dose I-131 Therapy

Cited by 69 publications

References 0 publications

Postsurgical thyroid remnant estimation by ^99mTc‐pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma

Postsurgical thyroid remnant estimation by ^99mTc‐pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma

Is Morbıdıty Hıgh in Completıon Thyroıdectomy?

2016 Russian clinical practice guidelines for differentiated thyroid cancer diagnosis and treatment

Contact Info

Product

Resources

About

Value of Post-Therapy Whole-Body I-131 Imaging in the Evaluation of Patients with Thyroid Carcinoma Having Undergone High-Dose I-131 Therapy

Cited by 69 publications

References 0 publications

Postsurgical thyroid remnant estimation by 99mTc‐pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma

Postsurgical thyroid remnant estimation by 99mTc‐pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma

Is Morbıdıty Hıgh in Completıon Thyroıdectomy?

2016 Russian clinical practice guidelines for differentiated thyroid cancer diagnosis and treatment

Contact Info

Product

Resources

About

Postsurgical thyroid remnant estimation by ^99mTc‐pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma

Postsurgical thyroid remnant estimation by ^99mTc‐pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma